On Tuesday, HTC released a statement to announce the launch of a $100 million fund, Vive X. The fund has been designed with the key objective of promoting the growth of startups focused on virtual reality (VR) across the world.
According to the details shared by HTC, the offices of the Vive X fund will be located on San Francisco, Beijing and Taipei. The VR startups to which the fund will be devoted will include accessories manufacturers, content creators and app developers.
The Vive X fund will be fostered by HTC as a global VR accelerator, and will, thus, be of immense significance for existing and new VR startups.
The launch of the Vive X fund reflects HTC’s serious commitment to making real inroads in the VR arena. Towards that end, HTC CEO Cher Wang said in the Tuesday statement that, “Virtual reality is changing the world, yet to do that effectively it needs a healthy ecosystem to expand into the mass market.”
Wang further added: "Through HTC Vive, we look forward to enabling global talent to create interesting and compelling content and to help shape the future of this industry."
At the PAX East event this weekend, Harmonix laid down its plans for Rock Band 4 game in 2016, revealing that it has plans underway to launch a big expansion pack of the game this fall.
According to Harmonix's announcement, the...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
In a Friday announcement, Fiat Chrysler said that it is recalling nearly 1.1 million vehicles due to a transmission shifter issue. The automaker said that the problem which has resulted in the recall can cause the affected vehicles to roll away...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a recent announcement, Amazon has revealed that it...
Sirin Labs, a 2013-founded stealth Israeli startup, has...
In an announcement made via a blog post on Thursday,...
In a Friday announcement, Fiat Chrysler said that it is...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).